Contract 36C25018N0007

Biomerieux Inc · Department Of Veterans Affairs · October 1, 2017

Firm Fixed PriceFull & Open CompetitionNAICS 325413IDIQ Task Order

Biomerieux Inc was awarded a federal contract by Department Of Veterans Affairs on October 1, 2017 for $368,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Ann Arbor, MI. This is a task or delivery order issued under parent IDIQ VA25114A0011. The contract has been modified 9 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on April 11, 2022. If all options are exercised, the contract could reach $1.41 million.

Obligated to date
$367.8K
$367,812
Current value
$1.41M
Modifications
9
Latest April 11, 2022

Contract details

PIID
36C25018N0007
Parent IDIQ
VA25114A0011
Award type
Bpa Call
Pricing
Firm Fixed Price
Competition
Full And Open Competition
NAICS
325413 · In-Vitro Diagnostic Substance Manufacturing
Product / service
Lease Or Rental Of Equipment- Medical, Dental, And Veterinary Equipment And Supplies
Place of performance
Ann Arbor, MI
First action
October 1, 2017
Latest action
April 11, 2022

Description

MICROBIOLOGY COST PER REPORTABLE TEST DE-OBLIGATION OF UNUSED FUNDS

Modification timeline

  • April 11, 2022
    Mod P00003
    $-11.9K
  • December 29, 2020
    Mod P00003
    CARDIAC MONITORING SERVICES
    $-3.9K
  • July 2, 2020
    Mod P00001
    COURT REPORTING SERVICES FOR DAYTON VAMC
    $-25.9K
  • March 2, 2020
    Mod P00002
    CARDIAC MONITORING SERVICES
    $-1.3K
  • May 9, 2019
    Mod P00001
    IGF::OT::IGF CARDIAC MONITORING SERVICES
    $-42.2K
  • October 11, 2018
    Mod P00002
    IGF::OT::IGF MICROBIOLOGY COST PER REPORTABLE TEST
    $-23.1K
  • May 27, 2018
    Mod P00001
    IGF::OT::IGF MICROBIOLOGY COST PER REPORTABLE TEST
    $-154.8K
  • October 1, 2017
    Base award
    COURT REPORTING SERVICES FOR DAYTON VAMC IGF::OT::IGF
    $35.0K
  • October 1, 2017
    Base award
    IGF::OT::IGF CARDIAC MONITORING SERVICES
    $288.1K
  • October 1, 2017
    Base award
    IGF::OT::IGF MICROBIOLOGY COST PER REPORTABLE TEST
    $307.8K

Similar contracts

RecipientAgencyDateObligated
Ortho-Clinical Diagnostics, IncDepartment Of Veterans AffairsApril 1, 2026$221.9K
Roche Diagnostics CorporationDepartment Of Veterans AffairsApril 1, 2026$735.4K
Abbott Laboratories Inc.Department Of Veterans AffairsApril 1, 2026$1.56M
Bio Rad Laboratories IncDepartment Of Veterans AffairsApril 1, 2026$189.7K
Beckman Coulter, IncDepartment Of Veterans AffairsMarch 31, 2026$95.6K
Veterans Healthcare Supply Solutions, IncDepartment Of Veterans AffairsMarch 31, 2026$176.8K

Top contractors in NAICS 325413

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Abbott Rapid Dx North America Llc651$3.51B
2Ihealth Labs Inc.4$2.13B
3Roche Diagnostics Corporation5,604$959.60M
4Siemens Healthcare Diagnostics Inc.818$641.45M
5Cepheid3,693$639.45M
6Remel Inc.4,525$464.47M
7Access Bio, Inc.5$340.72M
8Ortho-Clinical Diagnostics, Inc1,964$227.77M
9Quidel Corp96$194.78M
10Ortho-Clinical Diagnostics Inc2,494$183.46M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract 36C25018N0007?

Contract 36C25018N0007 is a federal contract awarded to Biomerieux Inc by Department Of Veterans Affairs on October 1, 2017 for $368,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 9 times since the base award.

Who won contract 36C25018N0007?

Biomerieux Inc won contract 36C25018N0007 from Department Of Veterans Affairs.

How much is contract 36C25018N0007 worth?

Contract 36C25018N0007 has obligated $368,000 to date, with a total potential value of $1.41 million if all options are exercised.